Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NovoStent Corp.

www.novostent.com

Latest From NovoStent Corp.

The Next Wave in Peripheral Vascular Interventions

The market for interventional devices designed to treat peripheral artery disease has long taken a backseat to the more high-profile interventional cardiology arena. However, with competitive and economic pressures now driving down prices and profits for coronary stents, manufacturers and investors alike are turning their attention to the still underpenetrated PAD opportunity, where device advancements are expanding the treatable patient population and could drive strong revenue growth in the years ahead.
Medical Device

Selected Start-Ups (9/04)

In Vivo briefly summarizes the technologies of these recently founded companies: Alimera Sciences Ic., CellCentric Ltd., NovoStent Corp., Plantacor Inc., Sadra Medical Inc. and Strata Pharmaceuticals Inc.
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
  • Therapeutic Areas
  • Cardiovascular
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • NovoStent Corp.
  • Senior Management
  • Contact Info
  • NovoStent Corp.
    Phone: (408) 235-1730
    1500 Wyatt Dr. #10
    Santa Clara, CA 95054
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register